Extracorporeal Photopheresis in Dermatological Diseases

Extracorporeal Photopheresis in Dermatological Diseases

Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as Sezary’s syndrome and mycosis fungoides. Over the past three decades, its immunotherapeutic properties have been tested o...

Full description

Bibliographic Details
Main Authors:	Hanna Terhaar, Mohammad Saleem, Nabiha Yusuf
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	International Journal of Molecular Sciences
Subjects:	extracorporeal photopheresis extracorporeal photochemotherapy autoimmune skin diseases immunotherapy dermatologic diseases
Online Access:	https://www.mdpi.com/1422-0067/25/5/3011

Similar Items

Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis
by: Thilo Gambichler, et al.
Published: (2022-05-01)

CLINICAL SIGNIFICANCE OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN COMPLEX TREATMENT OF LOCALIZED SCLERODERMA
by: O. A. Fomina, et al.
Published: (2016-02-01)

APPLICATION OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN SKIN LYMPHOMAS AND TRANSPLANTATION OF SOLID ORGANS
by: A. V. Kildyushevsky, et al.
Published: (2016-02-01)

EXTRACORPOREAL PHOTOCHEMOTHERAPY IN PSORIASIS AND PSORIATIC ARTHRITIS
by: E. S. Yakubovskaya, et al.
Published: (2016-06-01)

Clinical and immunological aspects of extracorporeal photochemotherapy for psoriasis and psoriatic arthritis
by: V A Molochkov, et al.
Published: (2012-10-01)

OF PHOTOPHERESIS IN KIDNEY TRANSPLANTATION
by: A. P. Faenko, et al.
Published: (2018-04-01)

Extracorporeal Therapy in Dermatology
by: Sumit Sen, et al.
Published: (2021-01-01)

Extracorporeal photopheresis: Review of technical aspects
by: Satyam Arora, et al.
Published: (2017-01-01)

Lessons from the discontinuation of extracorporeal photopheresis
by: Kyle R. Brownback
Published: (2017-06-01)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01)

CHANGES IN TUMOR NECROSIS FACTOR ALFA DURING TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS BY TRANSIMMUNIZATION METHOD
by: A. V. Kil'dyushevskiy, et al.
Published: (2016-07-01)

Extracorporeal photopheresis as a non-specific immune therapy of autoimmune diseases and skin T-cell lymphoma (a review of the literature and own studies)
by: A. V. Kil'dyushevskiy, et al.
Published: (2019-11-01)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
by: Aisling M. Flinn, et al.
Published: (2020-07-01)

Extracorporeal photopheresis in solid organ transplantation
by: A. V. Kildyushevsky, et al.
Published: (2020-10-01)

TREATMENT OF THE TUMOR STAGE OF MYCOSIS FUNGOIDES WITH EXTRACORPOREAL PHOTOCHEMOTHERAPY (A CASE DESCRIPT
by: V. A. Molochkov, et al.
Published: (2016-06-01)

CLINICAL EFFICACY OF EXTRA-CORPOREAL PHOTOCHEMOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. V. Molochkov, et al.
Published: (2016-02-01)

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
by: Mauricio Sarmiento Maldonado, et al.
Published: (2017-12-01)

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
by: Céline Coppard, et al.
Published: (2019-09-01)

Extracorporeal photopheresis in the treatment of the novel coronavirus disease COVID-19 (a case series)
by: A. V. Kildyushevsky, et al.
Published: (2020-09-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
by: Hind Rafei, et al.
Published: (2017-10-01)

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
by: Nadia Ninosu, et al.
Published: (2023-12-01)

Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults
by: Cécile Robinson, et al.
Published: (2017-03-01)

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
by: Oleg E. Akilov
Published: (2023-09-01)

Quilty Effect after Extracorporeal Photopheresis in a Patient with Severe Refractory Cardiac Allograft Rejection
by: Özgür Ulaş Özcan, et al.
Published: (2014-12-01)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
by: Yandy Marx Castillo-Aleman
Published: (2022-10-01)

Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model
by: Yuwei Lin, et al.
Published: (2024-03-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
by: Robin Reschke, et al.
Published: (2022-08-01)

A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction
by: Alberto Benazzo, et al.
Published: (2024-01-01)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
by: Maja-Theresa Dieterlen, et al.
Published: (2021-08-01)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
by: Matthew Mankarious, et al.
Published: (2020-01-01)

Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Crocchiolo Roberto, et al.
Published: (2021-02-01)

Extracorporeal photopheresis for the treatment of chronic graft versus host disease
by: Emin Kansu, et al.
Published: (2022-12-01)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
by: Ines Bojanic, et al.
Published: (2023-02-01)

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome
by: Ilana D. Breen, BS, et al.
Published: (2021-03-01)

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
by: Inga Hansen, et al.
Published: (2024-03-01)

Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis
by: Sara Bozzini, et al.
Published: (2024-03-01)

Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
by: Adrianna Spałek, et al.
Published: (2022-11-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)